Vanguard Personalized Indexing Management LLC Has $3.35 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Vanguard Personalized Indexing Management LLC increased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 10.9% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 15,847 shares of the medical research company’s stock after acquiring an additional 1,552 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in IQVIA were worth $3,347,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in IQV. Meiji Yasuda Asset Management Co Ltd. grew its holdings in IQVIA by 3.0% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 9,112 shares of the medical research company’s stock valued at $1,927,000 after purchasing an additional 264 shares during the last quarter. Mercer Global Advisors Inc. ADV grew its stake in IQVIA by 21.1% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 13,043 shares of the medical research company’s stock valued at $2,746,000 after buying an additional 2,277 shares during the last quarter. Argent Trust Co raised its holdings in IQVIA by 7.3% in the 2nd quarter. Argent Trust Co now owns 19,490 shares of the medical research company’s stock worth $4,121,000 after acquiring an additional 1,327 shares during the period. Clearstead Trust LLC lifted its position in IQVIA by 25.0% during the 2nd quarter. Clearstead Trust LLC now owns 360 shares of the medical research company’s stock worth $76,000 after acquiring an additional 72 shares during the last quarter. Finally, Virtu Financial LLC boosted its holdings in IQVIA by 302.1% during the second quarter. Virtu Financial LLC now owns 15,574 shares of the medical research company’s stock valued at $3,293,000 after acquiring an additional 11,701 shares during the period. 89.62% of the stock is owned by institutional investors.

Insider Transactions at IQVIA

In related news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

IQV has been the topic of a number of recent analyst reports. Evercore ISI lifted their price objective on IQVIA from $230.00 to $270.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 23rd. JPMorgan Chase & Co. upped their price target on IQVIA from $260.00 to $288.00 and gave the stock an “overweight” rating in a report on Monday, August 5th. Argus upgraded shares of IQVIA to a “strong-buy” rating in a research note on Wednesday, July 31st. Robert W. Baird upped their target price on shares of IQVIA from $235.00 to $251.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Finally, Morgan Stanley raised their price target on shares of IQVIA from $270.00 to $280.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 23rd. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $266.67.

IQVIA Price Performance

Shares of IQV stock opened at $244.62 on Friday. The stock’s fifty day simple moving average is $240.24 and its 200 day simple moving average is $234.25. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $261.73. The firm has a market cap of $44.57 billion, a price-to-earnings ratio of 33.42, a P/E/G ratio of 2.24 and a beta of 1.49. The company has a debt-to-equity ratio of 1.80, a current ratio of 0.85 and a quick ratio of 0.85.

IQVIA (NYSE:IQV) last posted its earnings results on Monday, July 22nd. The medical research company reported $2.64 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.07. IQVIA had a net margin of 9.39% and a return on equity of 28.59%. The business had revenue of $3.81 billion for the quarter, compared to analyst estimates of $3.79 billion. During the same quarter in the prior year, the firm earned $2.22 EPS. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. On average, analysts expect that IQVIA Holdings Inc. will post 10.25 earnings per share for the current fiscal year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.